Corporate Profile

Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class therapeutics for patients with autoimmune disease.

Landos was established as an incredibly productive research engine, with a portfolio of three novel targets anchoring libraries of immunometabolic modulation pathways, including seven first-in-class, once-daily therapies targeting 14 indications in the immunology space.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.